INTRODUCTION
Meneldor offers her customers the unique opportunity to co-invest alongside specialists, in
exciting early stage Biotech and Pharma companies. A sector often considered as very risky
and highly complex. Meneldor thoroughly studies the science behind her potential portfolio
companies. If the science is sound, then all other key aspects; IP, medical need, addressable
markets, competition, risk, management, financial needs, valuation, etc., are assessed. Only if
a target company meets our selection criteria, Meneldor will invest and invite her co-investors
to participate.
INVESTMENT FOCUS
Meneldor focuses on early stage biotech and pharma companies that (re)develop (New) Bio or
Chemical Molecular Entities or Repurposed drugs, that have outstanding technology with strong IP, address significant
unmet medical needs and attractive markets. We are especially scouting for companies that work
on relatively low risk and high growth opportunities. We mainly invest in projects which are in
preclinical, Phase I or early Phase II and in indications with preferably clear well defined clinical
endpoints. Our geographic focus is Europe.
CURRENT HOLDINGS AND PIPELINE
Meneldor has a very exciting pipeline. Details will be shared only under NDA. Our current holdings are:
2016: Xenikos B.V. (Netherlands)
2017: Atriva Therapeutics GmbH (Germany)
2018: Aptamer Group Ltd (UK)
2019: LightOx Ltd (UK)
2021: TagWorks Pharma (Netherlands)
2022: Hemispherian (Norway)
Company Details
- Employees
- 3
- Founded
- -
- Address
- Van Heemstraweg 123d, Druten,kh 6651,netherlands
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- info@meneldor.nl
- Keywords
- Biopharmaceutical, Strategic Program Development, Project Management, Management of technology and investments companies, Investment.
- HQ
- Druten, KH
Meneldor Questions
Meneldor's website is info@meneldor.nl
Meneldor's LinkedIn profile is https://nl.linkedin.com/company/meneldor-b-v
Meneldor has
3 employees.
View email and phone details for 3
employees at Meneldor.
Meneldor's industry is
Venture Capital and Private Equity Principals
Meneldor's top competitors are
Gwaihir,
Axeco,
Hemispherian As,
Kiplin Capital,
Avivia,
Main Capital Partners,
Group Nerisa,
Strikwerda Investments,
Gwaihir Robotics,
Green Park Investment Partners.
Meneldor's categories are Venture Capital and Private Equity Principals
Meneldor's founding year is 2016
